Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Registry of Irreversible Electroporation for the Ablation of Prostate Cancer With Use of Nanoknife Device; A Multi-Center, International Registry to Evaluate the Treatment of Prostate Cancer in Terms of Recurrence, Functional Outcomes and Safety.

NCT02255890 is registered in ClinicalTrials.gov with Clinical Research Office of the Endourological Society as lead sponsor.

NCT NCT02255890
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02255890 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Registry of Irreversible Electroporation for the Ablation of Prostate Cancer With Use of Nanoknife Device; A Multi-Center, International Registry to Evaluate the Treatment of Prostate Cancer in Terms of Recurrence, Functional Outcomes and Safety.
Lead sponsor
Clinical Research Office of the Endourological Society
Phase
Observational
Overall status
Unknown status
Start date
November 30, 2014
Completion date
April 30, 2025
Enrollment
361 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer